COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Cancer
Related studies linked through entity extraction aliases.
Cemiplimab in AlloSCT/SOT Recipients With CSCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
First-In-Human Study of EOS884448 in Participants with Advanced Cancers.
- Status
- COMPLETED
- Phase
- PHASE1
Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
- Status
- COMPLETED
- Phase
- PHASE1
Lenvatinib in Locally Advanced Invasive Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Effect of Laser Acupuncture on Constipation in Patients With Advanced Cancer
- Status
- UNKNOWN
- Phase
- NA
Crizotinib in ALK Rearranged Non-small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents
- Status
- COMPLETED
- Phase
- NA
Do Patients Want to Engage in Discussions Dedicated to Anticipating (DDA) Their Preferences of Care in the Event of Worsening Health Status?
- Status
- COMPLETED
- Phase
- N/A
The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- NA
Individual Patient Compassionate Use of GX-I7
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA
A Trial of ZL-1201 in Subjects With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Impact of a Resource-based Life Review Intervention on Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Study of GNX102 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Biomarkers For Immune Checkpoint Inhibitors
- Status
- COMPLETED
- Phase
- N/A
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1